Philips and Leeds Teaching Hospitals NHS Trust to set new standards for specialist integrated cardiac care
June 25 2020 - 04:00AM
Philips and Leeds Teaching Hospitals NHS Trust to set new standards
for specialist integrated cardiac care
June 25, 2020
Seven-year agreement puts patients at heart of service design to
support increased excellence across specialist care, research and
local care provision
Amsterdam, the Netherlands and Guildford, UK – Royal
Philips (NYSE: PHG, AEX: PHIA), a global leader in health
technology, and Leeds Teaching Hospitals NHS Trust today announced
a seven-year managed service agreement to deliver on the Trusts’
vision to set new standards of excellence for cardiac care in the
UK and globally. The partnership will combine the latest
innovations in technology for integrated cardiovascular solutions
to deliver on the quadruple aim: better health outcomes, lower cost
of care, and an improved experience for patients and staff. The
service improvement program will support the co-design of new
patient pathways and workflows, all with the aim of delivering the
best care experience for patients.
“The Cardiology team at Leeds Teaching Hospitals are very proud
of the quality of cardiac care we are able to deliver for our
patients,” said Dr Chris Pepper, Clinical Director for Cardiology
at Leeds Teaching Hospitals NHS Trust. “We see this partnership as
a hugely exciting and positive opportunity to improve this further.
We look forward to being able to provide state-of-the-art cardiac
imaging as part of a highly efficient and forward-looking
cardiology service for the people of Leeds and West Yorkshire. We
also look forward to a positive and collaborative working
relationship with Philips.”
The agreement includes six fully featured interventional cardiac
suites based on the Philips Azurion platform, including two
specialized electrophysiology suites and a structural heart suite,
as well as advanced patient monitoring and ultrasound systems. The
Azurion platform provides an intuitive, seamless approach for
minimally invasive procedures that will support Leeds’ clinicians
to focus on treating the patient, and its administrators as they
strive to improve productivity and efficiency through intelligent
resource management.
Dr Pepper continued, “We are now working through the backlog of
patients and other challenges created by the COVID-19 pandemic. We
need to keep services running and have been supported through our
partnership with Philips including in reorganizing lab allocations
and maintaining patient flow, which has been of substantial
benefit. Our cath labs are an essential part of our operations, so
when two of our systems recently needed urgent repair, we were
happy that Philips was able to resolve the issues without impact on
our daily workflow. Our state-of-the-art ultrasound systems have
also helped us maintain efficiency after the first wave of COVID-19
patients and will help streamline and facilitate further
recovery.”
"Cardiovascular disease is one of the world’s leading causes of
death [1] and in the UK we are now seeing more people dying of
heart disease at younger ages than in previous years,” said Neil
Mesher, General Manager of Philips UK & Ireland. “The COVID-19
pandemic has shown what we can achieve when we combine our
collective resources to combat an urgent, complex challenge. It’s
with this spirit that we look forward to working side-by-side with
Leeds Teaching Hospitals NHS Trust to improve the region’s cardiac
health.”
Leeds Cardiac Clinical Services Unit sees over 25,000 patients a
year and offers specialist cardiology services to a regional UK
population of over 5.4 million across West Yorkshire. As both a
local care provider and international specialism centre, the Trust
operates an aspirational international innovation programme that
not only benefits the local population but also the global
cardiology community by developing cutting-edge techniques to meet
challenging patient presentations. With both local and
international objectives, Leeds has decided to work in partnership
with Philips on a long-term basis to ensure these aspirations are
met.
[1]
https://www.bhf.org.uk/what-we-do/our-research/heart-and-circulatory-diseases-in-numbers/death-rates-over-time
For further information, please contact:
Mark GrovesPhilips Global Press OfficeTel: +31 631 639 916
Email: mark.groves@philips.com Twitter: mark_groves
Emily Wells-Burr Philips UK & IrelandTel: +44 7825 105
685Email: emily.wells-burr@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
enabling better outcomes across the health continuum from healthy
living and prevention, to diagnosis, treatment and home care.
Philips leverages advanced technology and deep clinical and
consumer insights to deliver integrated solutions. Headquartered in
the Netherlands, the company is a leader in diagnostic imaging,
image-guided therapy, patient monitoring and health informatics, as
well as in consumer health and home care. Philips generated 2019
sales of EUR 19.5 billion and employs approximately 81,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
- Leeds General Infirmary
- Leeds General Infirmary panorama
- Philips Azurion Image Guided Therapy platform
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Feb 2024 to Mar 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Mar 2023 to Mar 2024